By Alena Kuzub
Northeastern University professor Mansoor Amiji has developed targeted drug delivery methods for a variety of diseases, including cancer, inflammatory diseases and central nervous system disorders.
His expertise ranges from the development of these delivery systems to the development of biomaterials from natural and synthetic polymers to the application of nanotechnology in disease diagnostics, imaging and therapy.
In recognition of his career achievements in pharmaceutical sciences, Amiji was elected one of the American Association for the Advancement of Science’s 2024 lifetime fellows.
“I’m really grateful to AAAS for selecting me to receive this honor,” says Amiji, university distinguished professor of pharmaceutical sciences and chemical engineering. “Nothing happens in a silo, and my every success is very much tied to all the students and postdocs who have trained and continue to work in my lab. I also have had some amazing mentors.”
Amiji is one of 471 scientists, engineers and innovators across two dozen disciplinary sections to receive the distinguished honor this year. The AAAS is one of the world’s largest general scientific communities.
“My affiliation in AAAS is really important because we continue to strive for greater awareness of the role of science and how scientific minds and ultimately scientific discoveries are so essential for the economic well-being of the United States and continue to allow us to be prosperous and continue to allow us to be healthy,” Amiji says.
Amiji first became excited about research while completing his pharmacy degree at Northeastern in the 1980s, working in a lab focused on improving cancer drugs safety by making them more selective to tumor cells.
